Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Diseases × Genotype × Breast × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Pancreatic Neoplasms 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Fanconi Anemia, Complementation Group D1 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Diseases 1 Breast Carcinoma In Situ 1

Interventions

palbociclib 6 Letrozole 6 Docetaxel 6 Anastrozole 6 exemestane 5 Trastuzumab 5 Fulvestrant 5 ribociclib 4 entinostat 4 abemaciclib 4 Cyclophosphamide 4 pyrotinib 3 Doxorubicin 3 Sodium Chloride 2 Paclitaxel 2 Lapatinib 2 Gonadotropin-Releasing Hormone 2 Exercise 2 Everolimus 2 Epirubicin 2 Capecitabine 2 Botulinum Toxins, Type A 2 AZD9833 2 tucatinib 1 sacubitril and valsartan sodium hydrate drug combination 1 pertuzumab 1 pembrolizumab 1 pegfilgrastim 1 ipatasertib 1 gadoterate meglumine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05006196 2025-12-01

IMOGEN

Perspectum

Active not recruiting

Breast Diseases, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡